United States · Platforms & data · Finviz

DSS, Inc. Announces SEC Declaration of Effectiveness of Form F-4 Registration Statement, Marking Major Milestone Toward Closing of Proposed Business Combination

Published by Finviz · United States 10 h ago

Special meeting of Impact Biomedical stockholders to approve the proposed Business Combination scheduled for November 13, 2026, at 10:00 a.m. Eastern Standard Time Upon closing,…

Read the full article on Finviz Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (finviz.com)

Also worth reading

MarketBeat

Abbott Laboratories (NYSE:ABT) Stock Sale Revealed by Rep. Thomas H. Kean, Jr.

Seeking Alpha

Michael Burry adds to BYD, SFM, JD, sees up to 140% potential in Fiserv

CNBC

Blackstone president calls for more equity to fund AI buildout as debt risks mount

The Motley Fool

Vertex (VRTX) Q3 2026 Earnings Call Transcript

Investing.com

Why is Virgin Australia stock surging today?

MarketWatch